HIGH MMP3 SERUM LEVELS ARE ASSOCIATED WITH EXTENSIVE STRUCTURAL DAMAGE IN PATIENTS WITH EARLY, TREATMENT NAIVE RHEUMATOID ARTHRITIS (RA): TWO YEARS PROSPECTIVE CLINICAL AND ULTRASONOGRAPHIC STUDY

被引：0
|
作者：
Prodanovic, S. Z. [1 ]
Radunovic, G. [1 ]
Sefik-Bukilica, M. [1 ]
Zlatanovic, M. [1 ]
Simic-Pasalic, K. [1 ]
Seric, S. [2 ]
Damjanov, N. [1 ]
机构：
[1] Inst Rheumatol, Belgrade, Serbia
[2] Inst Rheumatol, Radiol Dept, Belgrade, Serbia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.4002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0064
引用
收藏
页码：792 / 792
页数：1
相关论文
共 24 条
  • [1] Correlation of MMP3 serum levels with disease activity and structural damage in patients with rheumatoid arthritis
    Skacelova, M.
    Hermanova, Z.
    Horak, P.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126
  • [2] Serum levels of matrixmetalloproteinases MMP1 (collagenase) and MMP3 (stromelysin) before and after treatment with leflunamide in patients with rheumatoid arthritis
    Mangge, H.
    Gratze, P.
    Hermann, S.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2001, 3 (Suppl 2)
  • [3] Serum levels of matrixmetalloproteinases MMP1 (collagenase) and MMP3 (stromelysin) before and after treatment with leflunamide in patients with rheumatoid arthritis
    H Mangge
    P Gratze
    S Hermann
    [J]. Arthritis Research & Therapy, 3
  • [4] DOES HIGH BASELINE LEVEL OF MATRIX METALLPROTEINASES 3 (MMP3) INDICATE MORE MTP5 JOINT EROSIONS IN EARLY RHEUMATOID ARTHRITIS PATIENTS? (THE 2-YEAR PROSPECTIVE ULTRASONOGRAPHIC STUDY)
    Prodanovic, S.
    Bukilica, M. Sefik
    Colic, J.
    Seric, S.
    Damjanov, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 265 - 265
  • [5] HIGH ULTRASONOGRAPHIC SCORES PERSIST AMONG PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION WITH NORMAL SERUM MMP-3 VALUES
    Okano, T.
    Koike, T.
    Tada, M.
    Sugioka, Y.
    Mamoto, K.
    Wakitani, S.
    Nakamura, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 305 - 306
  • [6] THE IMPORTANCE OF BIOMARKERS (RF, ACPA AND MMP-3) SERUM LEVELS OF RHEUMATOID ARTHRITIS (RA) IN PREDICTION BONE EROSIONS IN PATIENTS WITH EARLY RA AND NO VISIBLE RADIOGRAPHIC STRUCTURAL DAMAGES-AN ECHOSONOGRAPHIC STUDY
    Prodanovic, S. Z.
    Radunovic, G.
    Sefic-Bukilica, M.
    Seric, S.
    Damjanov, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 981 - 981
  • [7] Serum and synovial matrix metalloproteinases 1 and 3 in patients with early rheumatoid arthritis: potentially prospective biomarkers of ultrasonographic joint damage and disease activity
    Maryam A. Abdelrahman
    Hossam M. Sakr
    Menat A. A. Shaaban
    Naglaa Afifi
    [J]. The Egyptian Journal of Internal Medicine, 2019, 31 (4) : 965 - 971
  • [8] Matrix Metalloproteinases-3 Baseline Serum Levels in Early Rheumatoid Arthritis Patients without Initial Radiographic Changes: A Two-Year Ultrasonographic Study
    Prodanovic, Slavica Z.
    Radunovic, Goran
    Babic, Dragan
    Ristic, Biljana
    Sefik-Bukilica, Mirjana
    Zlatanovic, Maja
    Simic-Pasalic, Katarina
    Seric, Srdjan
    Vujasinovic-Stupar, Nada
    Samardzic, Janko
    Damjanov, Nemanja
    [J]. MEDICAL PRINCIPLES AND PRACTICE, 2018, 27 (04) : 378 - 386
  • [9] Stromelysin-1 serum levels are predictive of joint destruction in early rheumatoid arthritis (RA). A 3-year prospective study.
    Combe, B
    Ribbens, C
    Dougados, M
    Cantagrel, A
    Goupille, P
    Bozonnat, MC
    Sibilia, J
    Sany, J
    Daures, JP
    Malaise, M
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S186 - S186
  • [10] Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study
    van der Heijde, Desiree
    Durez, Patrick
    Schett, Georg
    Naredo, Esperanza
    Ostergaard, Mikkel
    Meszaros, Gabriella
    De Leonardis, Francesco
    de la Torre, Inmaculada
    Lopez-Romero, Pedro
    Schlichting, Douglas
    Nantz, Eric
    Fleischmann, Roy
    [J]. CLINICAL RHEUMATOLOGY, 2018, 37 (09) : 2381 - 2390
123